View Item 

Show simple item record

Recurrent primary sclerosing cholangitis in the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients
dc.contributor.authorGordon, Fredric D.
dc.contributor.authorGoldberg, David S.
dc.contributor.authorGoodrich, Nathan P.
dc.contributor.authorLok, Anna S. F.
dc.contributor.authorVerna, Elizabeth C.
dc.contributor.authorSelzner, Nazia
dc.contributor.authorStravitz, R. Todd
dc.contributor.authorMerion, Robert M.
dc.date.accessioned2016-10-17T21:20:23Z
dc.date.available2017-11-01T15:31:30Zen
dc.date.issued2016-09
dc.identifier.citationGordon, Fredric D.; Goldberg, David S.; Goodrich, Nathan P.; Lok, Anna S. F.; Verna, Elizabeth C.; Selzner, Nazia; Stravitz, R. Todd; Merion, Robert M. (2016). "Recurrent primary sclerosing cholangitis in the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients." Liver Transplantation 22(9): 1214-1222.
dc.identifier.issn1527-6465
dc.identifier.issn1527-6473
dc.identifier.urihttps://hdl.handle.net/2027.42/134274
dc.publisherWiley Periodicals, Inc.
dc.titleRecurrent primary sclerosing cholangitis in the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelSurgery and Anesthesiology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134274/1/lt24496_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134274/2/lt24496.pdf
dc.identifier.doi10.1002/lt.24496
dc.identifier.sourceLiver Transplantation
dc.identifier.citedreferenceKashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, et al. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. J Gastrointest Surg 2009; 13: 1480 – 1486.
dc.identifier.citedreferenceKashyap R, Safadjou S, Chen R, Mantry P, Sharma R, Patil V, et al. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases – an analysis of the UNOS database. J Gastrointest Surg 2010; 14: 1362 – 1369.
dc.identifier.citedreferenceBerg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 2011; 54: 1313 – 1321.
dc.identifier.citedreferenceLupascu C, Lerut J. Allograft inflow – concern in liver transplantation after intraoperative radiotherapy for cholangiocarcinoma. Chirurgia (Bucur) 2014; 109: 837 – 842.
dc.identifier.citedreferenceMantel HT, Rosen CB, Heimbach JK, Nyberg SL, Ishitani MB, Andrews JC, et al. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 2007; 13: 1372 – 1381.
dc.identifier.citedreferenceGoldberg DS, French B, Thomasson A, Reddy KR, Halpern SD. Current trends in living donor liver transplantation for primary sclerosing cholangitis. Transplantation 2011; 91: 1148 – 1152.
dc.identifier.citedreferenceEgawa H, Ueda Y, Ichida T, Teramukai S, Nakanuma Y, Onishi S, Tsubouchi H. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry. Am J Transplant 2011; 11: 518 – 527.
dc.identifier.citedreferenceGoldberg DS, French B, Abt PL, Olthoff K, Shaked A. Superior survival using living donors and donor‐recipient matching using a novel living donor risk index. Hepatology 2014; 60: 1717 – 1726.
dc.identifier.citedreferenceGraziadei IW. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2002; 8: 575 – 581.
dc.identifier.citedreferenceMayo Clinic. Locally written SAS macros. http://www.mayo.edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statistics-informatics/software/locally-written-sas-macros. Accessed June 29, 2016.
dc.identifier.citedreferenceWeismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP. The challenges in primary sclerosing cholangitis – aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 2008; 48 ( suppl 1 ): S38 – S57.
dc.identifier.citedreferenceGordon F. Recurrent primary sclerosing cholangitis: Clinical diagnosis and long‐term management issues. Liver Transpl 2006; 12 ( suppl 2 ): S73 – S75.
dc.identifier.citedreferenceTamura S, Sugawara Y, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Recurrence of primary sclerosing cholangitis after living donor liver transplantation. Liver Int 2007; 27: 86 – 94.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
lt24496_am.pdf
Size:
779.4KB
Format:
PDF
View/Open
Name:
lt24496.pdf
Size:
248.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.